Publication Type : Journal Article
Source : National Journal of Physiology, Pharmacy and Pharmacology, Volume 7, Issue 9, p.1007-1008 (2017)
Url : https://www.njppp.com/?mno=270197
Campus : Kochi
School : School of Pharmacy
Department : Pharmacy Practice
Year : 2017
Abstract : Leucovorin (LCV) acts as an essential coenzyme for nucleic acid synthesis and also it is an active metabolite of folic acid. LCV can be used to selectively “rescue” cells from the adverse effects of methotrexate (MTX). Here, we report a case of LCV-induced hypersensitivity reaction when used in combination with high dose MTX (HDMTX). We describe a 2-years-old female baby diagnosed with B-cell acute lymphoblastic leukemia on chemotherapy with pediatric berlin-frankfurt-munster protocol; she is on HDMTX and injection LCV. After initiation of LCV (folinic acid) at 42 h she was noted to have hypersensitivity reaction. Despite reaction to LCV is uncommon, one should be aware of the reactions that can be caused by LCV.
Cite this Research Publication : A. Mathew, Chandran, C., Prabhu, R., and Reghu, R., “Leucovorin-induced hypersensitivity reaction in acute lymphoblastic leukemia - A case report”, National Journal of Physiology, Pharmacy and Pharmacology, vol. 7, no. 9, pp. 1007-1008, 2017.